RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 111 filers reported holding RHYTHM PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $511,000 | -23.5% | 51,161 | 0.0% | 0.00% | – |
| Q3 2021 | $668,000 | -33.3% | 51,161 | 0.0% | 0.00% | – |
| Q2 2021 | $1,002,000 | -27.7% | 51,161 | -21.4% | 0.00% | – |
| Q1 2021 | $1,385,000 | -70.8% | 65,108 | -59.2% | 0.00% | -100.0% |
| Q4 2020 | $4,740,000 | +37.2% | 159,428 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $3,455,000 | -32.7% | 159,428 | -30.7% | 0.00% | 0.0% |
| Q2 2020 | $5,133,000 | +46.5% | 230,195 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $3,504,000 | -33.7% | 230,195 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $5,285,000 | +463.4% | 230,195 | +667.3% | 0.00% | – |
| Q2 2018 | $938,000 | -5.7% | 30,000 | -40.0% | 0.00% | – |
| Q1 2018 | $995,000 | -31.5% | 50,000 | 0.0% | 0.00% | -100.0% |
| Q4 2017 | $1,453,000 | – | 50,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 4,909,956 | $142,977,919 | 8.04% |
| Opaleye Management Inc. | 735,000 | $21,403,200 | 7.44% |
| Frazier Life Sciences Management, L.P. | 1,894,000 | $55,153,280 | 3.43% |
| RA Capital Management | 5,516,067 | $160,627,871 | 3.26% |
| Altium Capital Management LP | 170,000 | $4,950,400 | 2.52% |
| Samsara BioCapital, LLC | 345,293 | $10,054,932 | 2.16% |
| Rock Springs Capital Management LP | 1,760,865 | $51,276,389 | 1.23% |
| Parkman Healthcare Partners LLC | 157,862 | $4,596,941 | 1.22% |
| Baker Brothers Advisors | 6,354,608 | $185,046,185 | 1.11% |
| EAM Investors, LLC | 164,695 | $4,795,918 | 0.99% |